검색어: kontroliranih (슬로베니아어 - 영어)

v večih kontroliranih
as with all growth factors, there is a concern that epoetins could stimulate the growth of tumours.

v kontroliranih klinič preizkuš
special precautions for disposal of unused medicinal products or waste materials derived from such medicinal products, if appropriate

neučinkovitost v kontroliranih kliničnih preskušanjih
lack of efficacy in controlled clinical trials

kategorizaciji kontroliranih in nadzorovanih območij;
categorisation of controlled and supervised areas;

rezultati ključnih s placebom kontroliranih študij
results from pivotal placebo-controlled studies

neželeni učinki v s placebom kontroliranih študijaha
adverse reactions in placebo-controlled studiesa

odziv po acr v raziskavah, kontroliranih s placebom
acr responses in placebo-controlled trials

nja dvojno slepih, s placebom kontroliranih študijah.
r severe disease (cdai score > 300 and concomitant corticosteroid and/ or immunosuppressants)

zadostnih in dobro kontroliranih študij pri nosečnicah ni.
there are no adequate and well-controlled studies in pregnant women.

(dddddddd) kategorizacijo kontroliranih in nadzorovanih območij;
(dddddddd) the categorisation of controlled and supervised areas;

20 zadostnih in dobro kontroliranih študij pri nosečnicah ni.
20 olanzapine.

ustreznih in dobro kontroliranih preskušanj aripiprazola pri nosečnicah ni.
there are no adequate and well-controlled trials of aripiprazole in pregnant women.

anjih, kontroliranih s placebom (ki so trajali 6 do 12
pharmaceutical form and contents

33 pri nosečnicah ni ustreznih in dobro kontroliranih preskušanj z darunavirjem.
pregnancy there are no adequate and well controlled studies with darunavir in pregnant women.

pri 6– 9% bolnikov, zdravljenih s pioglitazonom leto dni v kontroliranih
8 oedema was reported in 6 – 9% of patients treated with pioglitazone over one year in controlled clinical trials.

opomba: odmerjanje aldeslevkina se mora izvajati v kontroliranih aseptičnih pogojih.
note: dispensing of aldesleukin must be carried out under controlled aseptic conditions.

kontroliranih preskušanj, ki bi dokazovala klinično koristnost ali podaljšanje preživetja, ni.
there are no controlled trials demonstrating a clinical benefit or increased survival.

odziv po acr v raziskavah, kontroliranih s placebom (odstotek bolnikov) odziv
acr responses in placebo-controlled trials

odziv acr v študijah psoriatičnega artritisa, kontroliranih s placebom (odstotek bolnikov)
acr response in placebo-controlled psoriatic arthritis studies (percent of patients)

pogostnosti neželenih učinkov, zabeleženih v kontroliranih kliničnih študijah in postmarketinških izkušnjah, so:
incidence of adverse reactions from controlled clinical studies and post-marketing experience are: